DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyer, C. S.
Right arrow Articles by Petersen, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyer, C. S.
Right arrow Articles by Petersen, D. R.

The metabolism of 3,7-dimethyl-2,6-octadienal (citral) in rat hepatic mitochondrial and cytosolic fractions. Interactions with aldehyde and alcohol dehydrogenases

CS Boyer and DR Petersen

Molecular Toxicology and Enviornmental Health Sciences Program, Univeristy of Colorado Health Sciences Center, Boulder.

Citral (3,7-dimethyl-2,6-octadienal), a flavoring and fragrance agent, is associated with a variety of biochemical and toxicological effects. Reports of the in vivo metabolism of citral suggest that a primary route of metabolism is conversion to the corresponding acid species presumably by aldehyde dehydrogenases (ALDH). In the present study, hepatic mitochondrial and cytosolic fractions were prepared from male Sprague-Dawley rats to assess in vitro metabolism of citral. Evidence of ALDH-mediated citral oxidation was not seen in either subcellular fraction. On the contrary, citral was found to be a potent inhibitor of acetaldehyde oxidation by the low-KM mitochondrial form of ALDH. Measurement of the in vitro acetaldehyde oxidation rates of this isozyme in the presence of citral lead to the estimation of a Ki of 360 nM. Further studies of citral effects on low-KM mitochondrial ALDH indicate that inhibition is by a linear mixed-type mechanism and does not involve citral binding at the NAD+ binding site. In addition, it was observed that citral was readily reduced to the corresponding alcohol by alcohol dehydrogenase (ADH) in the cytosolic fraction. The reduction of citral in the presence of NADH proceeded at two distinct rates; an initial "fast" rate followed by a "slow" rate. Individual kinetic constants were calculated for the two rates. It is possible that the differential ADH-mediated reduction rates of citral are the result of varying affinities for the enzyme of the two citral isomers, geranial (trans) and neral (cis).(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 19, Issue 1, pp. 81-86, 01/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
L. J. Christopher, D. Cui, W. Li, A. Barros Jr., V. K. Arora, H. Zhang, L. Wang, D. Zhang, J. A. Manning, K. He, et al.
Biotransformation of [14C]Dasatinib: In Vitro Studies in Rat, Monkey, and Human and Disposition after Administration to Rats and Monkeys
Drug Metab. Dispos., July 1, 2008; 36(7): 1341 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
S. A. Marchitti, R. A. Deitrich, and V. Vasiliou
Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde Dehydrogenase
Pharmacol. Rev., June 1, 2007; 59(2): 125 - 150.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.